Smith M. L., Seo Y. R. Sensitivity of cyclin E-overexpressing cells to cisplatin/Taxol combinations. Anticancer Res., 20: 2537- ... cisplatin, mitomycin C, methotrexate, vincristine, and vinblastine). Comparison of the gene expression profiles of the tumors ... cisplatin; GPX, glutathione peroxidase; MAP2K3, mitogen-activated protein kinase kinase 3; MDR, multidrug resistance; NSCLC, ...
The human cMOAT cDNA hybridized a 6.5-kb mRNA that was expressed 4- to 6-fold higher by three cisplatin-resistant cell lines ... A Human Canalicular Multispecific Organic Anion Transporter (cMOAT) Gene Is Overexpressed in Cisplatin-resistant Human Cancer ... A Human Canalicular Multispecific Organic Anion Transporter (cMOAT) Gene Is Overexpressed in Cisplatin-resistant Human Cancer ... A Human Canalicular Multispecific Organic Anion Transporter (cMOAT) Gene Is Overexpressed in Cisplatin-resistant Human Cancer ...
The effects of cisplatin and carboplatin on this DNA were the same once bound to the same extent. About a 100-fold larger dose ... Rate constants for the aquation at 37°C of cisplatin and carboplatin of 8 × 10-5 and 7.2 × 10-7 s-1, respectively, were ... A similar, although faster, accumulation of cross-links was seen when cisplatin was bound to DNA. The loss of the 14C-CBDCA ... The kinetics of the aquation reactions of cisplatin and carboplatin and their subsequent reactions with DNA, both in vitro and ...
Inhibition of NOTCH3 signalling significantly enhances sensitivity to cisplatin in EBV-associated nasopharyngeal carcinoma. J ...
In vitro and in vivo molecular evidence of genistein action in augmenting the efficacy of cisplatin in pancreatic cancer. Int J ...
... and ifosfamide and subadditive effects with doxorubicin and cisplatin. Accordingly, combined treatment with NVP-AEW541 and ...
Wang X., Wong S. C., Pan J., Tsao S. W., Fung K. H., Kwong D. L., Sham J. S., Nicholls J. M. Evidence of cisplatin-induced ... and cisplatin; a somewhat weaker response was seen with ionizing radiation, cytarabine, and etoposide; and the weakest effect ... investigators have demonstrated the induction of the senescent phenotype in different tumor cell lines treated with cisplatin ( ...
Imatinib Sensitizes Bcr-Abl+ Cells to Cisplatin. *. Loss of S1P Lyase Upregulates Bcl-2 ...
Imatinib Sensitizes Bcr-Abl+ Cells to Cisplatin. *. Loss of S1P Lyase Upregulates Bcl-2 ...
Imatinib Sensitizes Bcr-Abl+ Cells to Cisplatin. *. Loss of S1P Lyase Upregulates Bcl-2 ...
Imatinib Sensitizes Bcr-Abl+ Cells to Cisplatin. *. Loss of S1P Lyase Upregulates Bcl-2 ...
Imatinib Sensitizes Bcr-Abl+ Cells to Cisplatin. *. Loss of S1P Lyase Upregulates Bcl-2 ...